# OC-01 (Varenicline) Nasal Spray and Dry Eye Signs and Symptoms in Daily Disposable Contact Lens Wearers

> **NCT05161208** · PHASE4 · COMPLETED · sponsor: **Center for Ophthalmic and Vision Research, LLC** · enrollment: 75 (actual)

## Conditions studied

- Dry Eye

## Interventions

- **DRUG:** OC-01 (varenicline 0.6mg/ml) Nasal Spray
- **DRUG:** Placebo (vehicle) nasal spray

## Key facts

- **NCT ID:** NCT05161208
- **Lead sponsor:** Center for Ophthalmic and Vision Research, LLC
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-03
- **Primary completion:** 2022-07-25
- **Final completion:** 2022-07-25
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2022-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05161208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05161208, "OC-01 (Varenicline) Nasal Spray and Dry Eye Signs and Symptoms in Daily Disposable Contact Lens Wearers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05161208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*